Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients

Table 1

Characteristics of studied groups.

Variable	SP-MS patients	RR-MS patients	Control group
Number	40	30	48
Age (years)		^###
Female sex number (%)	27 (67.5)	20 (66.6)	32 (66.6)
Disease duration from onset (years)		^###	N/A
EDSS score		^###	N/A

EDSS: Expanded Disability Status Scale; MS: multiple sclerosis; RR: relapsing-remitting; SP: secondary progressive. Data are expressed as (SD), vs. control group; ^### vs. SP-MS.